These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 580592)

  • 21. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent of etozolin elimination of kidney function. Single dose experiments in patients with renal insufficiency.
    Knauf H; Hasenfuss G; Wais U; Schollmeyer P; Mutschler E
    Arzneimittelforschung; 1980; 30(10):1791-3. PubMed ID: 7192116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum glycoside levels by rubidium assay.
    Ritzmann LW; Bangs CC; Coiner D; Custis JM; Walsh JR
    Arch Intern Med; 1973 Dec; 132(6):823-30. PubMed ID: 4757255
    [No Abstract]   [Full Text] [Related]  

  • 24. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of sulfaclomide and sulfamerazine in patients with impaired renal function after first and after repeated application.
    Traeger A; Stein G
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):315-20. PubMed ID: 892948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of digoxin upon the exercise ECG of healthy men (author's transl)].
    Jaeschke M; Erbel R; Fallen H; Belz GG
    Med Klin; 1976 Nov; 71(47):2059-65. PubMed ID: 1004353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
    Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
    Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.
    Ikeda H; Kihira K; Kuwata N; Arai S; Kimura Y; Miyake K; Kitaura T; Fujimura K; Kuramoto A; Fukuchi H
    Hiroshima J Med Sci; 1996 Jun; 45(2):57-62. PubMed ID: 8810132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma elimination of cardiac troponin I in end-stage renal disease.
    Ellis K; Dreisbach AW; Lertora JL
    South Med J; 2001 Oct; 94(10):993-6. PubMed ID: 11702827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment.
    Dittrich HC; Gupta DK; Hack TC; Dowling T; Callahan J; Thomson S
    J Card Fail; 2007 Oct; 13(8):609-17. PubMed ID: 17923351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical experience with the cardiac glycoside Gitoformat (author's transl)].
    Benda L; Zenz W
    Med Klin; 1978 Jul; 73(30):1081-4. PubMed ID: 672762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum glycoside level in old age. Problems of course control in glycoside therapy].
    Schwarzfischer VP
    Fortschr Med; 1976 May; 94(14):841-6. PubMed ID: 818003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics of intravenous mezlocillin in patients with normal and impaired renal function (author's transl)].
    Cano JP; Rigault JP; Gevaudan MJ; Saingra S; Murisasco A; Charpin J
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):335-9. PubMed ID: 6460972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetics of digoxin and methyldigoxin in patients with acute hepatitis (author's transl)].
    Zilly W; Richter E; Rietbrock N
    Med Klin; 1978 Mar; 73(13):463-9. PubMed ID: 634206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacokinetics of nimodipine in normal and impaired renal function.
    Kirch W; Rämsch KD; Dührsen U; Ohnhaus EE
    Int J Clin Pharmacol Res; 1984; 4(5):381-4. PubMed ID: 6519852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of long-term drugs on alfentanil clearance in patients undergoing renal transplantation.
    Koehntop DE; Noormohamed SE; Fletcher CV
    Pharmacotherapy; 1994; 14(5):592-9. PubMed ID: 7997393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Plasma concentrations and elimination of methyl proscillaridin in renal failure (author's transl)].
    Belz GG; Nübling H; Schmidt-Wiederkehr P; Franz HE
    Klin Wochenschr; 1974 Nov; 52(22):1078-81. PubMed ID: 4475331
    [No Abstract]   [Full Text] [Related]  

  • 40. [Plasma levels, elimination and cumulation of proscillaridin in renal failure (author's transl)].
    Belz GG; Brech WJ
    Klin Wochenschr; 1974 Jul; 52(13):640-4. PubMed ID: 4859058
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.